Treatment concepts of acute promyelocytic leukemia
- 30 November 2005
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 56 (2), 261-274
- https://doi.org/10.1016/j.critrevonc.2004.08.009
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemiaBlood, 2004
- Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA groupBlood, 2003
- Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoringLeukemia, 2002
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemiaBritish Journal of Haematology, 1997
- Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PMLCell, 1991
- Cytosine arabinoside in the treatment of acute myeloid leukemia: The role and place of high-dose regimensAnnals of Hematology, 1991
- The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locusNature, 1990
- Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17Science, 1990
- Acute promyelocytic leukemiaAmerican Journal of Hematology, 1979